脓毒症腹部手术患者循环干细胞、HIF-1与SDF-1的随机对照研究方案
本研究为前瞻性随机对照试验方案,针对复杂性腹腔感染所致脓毒症行腹部大手术患者,比较标准常规治疗联合或不联合体外血液灌注治疗,并设非脓毒症术后对照与健康志愿者。主要检测外周血EPC(CD133/CD34)、HIF-1及SDF-1a的时间变化及相互关系与结局关联。
要点
- 脓毒症组随机分为常规治疗与常规加体外血液灌注治疗两亚组。
- 检测时间点为术前及术后24小时、72小时、7天、10天。
- EPC与HIF-1用流式细胞术检测,SDF-1a用ELISA检测。
核心结论
- 研究旨在阐明脓毒症腹部手术后循环EPC、HIF-1与SDF-1a的时间变化、相互关系及其与结局的关联。
研究设计与样本
- 前瞻性随机对照试验方案,设脓毒症组、非脓毒症术后对照组及健康志愿者组。
- 脓毒症组随机接受单纯常规治疗或常规治疗联合体外血液灌注治疗。
- 脓毒症组与对照组于术前、术后24小时、72小时、7天、10天采集外周血,健康组仅术前采集。
关键数值与推荐
- EPC以CD133/CD34标记,与HIF-1计数均用流式细胞术测定。
- 血浆SDF-1a浓度用酶联免疫吸附试验测定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sepsis caused by complicated intra-abdominal infection is associated with high mortality. Loss of endothelial barrier integrity, inflammation, and impaired cellular oxygen have been shown to be primary contributors to sepsis. To date, little is known regarding the pathway for the mobilization of endothelial progenitor cells (EPCs) from the bone marrow in sepsis whereas stromal-cell-derived factor 1a (SDF-1a) and hypoxia inducible factor 1 (HIF-1) seem to have a role in the EPC response to hypoxic microenvironments. The aims of the study are: (a) to determine the time course of the levels of circulating EPCs (CD133/CD34), SDF-1a, and HIF-1 in septic patients undergoing major abdominal surgery (group S), (b) to investigate the relationship between CD133/CD34, HIF-1, and SDF-1a, and (c) to investigate the relationship of these factors with the outcome of group S patients treated with standard conventional therapy alone (CT) or with the addition of extracorporeal hemoperfusion therapy (HCT). METHODS/DESIGN: Patients undergoing major abdominal surgery will be allocated into groups: postoperative non-septic patients in an emergency surgical ward (group C) and postoperative septic patients in an intensive care unit (group S). The latter will be randomized to receive CT alone (S1) or with HCT (S2). Healthy volunteers (group H) will be recruited at University Hospital Foggia. Peripheral blood (PB) samples will be collected preoperatively (T0), at 24 h (T1), 72 h (T2), 7 (T3), and 10 (T4) postoperative days in groups S and C, and at T0 in group H. The CD34/133 cells and HIF-1 counts will be determined by flow cytometer analysis. The concentration of SDF-1a in plasma will be calculated by enzyme-linked immunosorbent assay analysis (ELISA). DISCUSSION: This prospective randomized clinical trial is designed to investigate circulating stem cells, levels of HIF-1 and SDF-1a, and their interrelationship in septic postoperative abdominal surgical patients treated with CT alone or with HCT. The rationale is that an integrated understanding of the role of hypoxia-related factors and EPCs in PB of septic patients could indicate which molecular processes need to be regulated to recover the innate immunity homeostasis. Understanding the function of EPCs in sepsis may provide innovative diagnostic and therapeutic approaches to improve the prognosis of this syndrome. TRIAL REGISTRATION: ClinicalTrials.gov: NCT02589535 . Registered on 28 October 2015.
引用
- Cotoia A, Mirabella L, Altamura S, et al. Circulating stem cells, HIF-1, and SDF-1 in septic abdominal surgical patients: randomized controlled study protocol. Trials. 2018. PMID: 29530072. doi:10.1186/s13063-018-2556-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。